How Pfizer Came to Pass on Early GLP‑1 Research in the Early 1990s: An Insider View
TL;DR Jeffrey Flier recounts his group's late-1980s effort to develop GLP-1–based metabolic therapies under a Pfizer–California Biotechnology alliance. Despite encouraging…